Risk of T2DM and impaired fasting glucose among pcos subjects: Results of an 8-year follow-up
- 108 Downloads
Women with polycystic ovary syndrome (PCOS) often develop type 2 diabetes mellitus (T2DM). To determine the magnitude of risk of developing T2DM among women with PCOS, development of T2DM was prospectively assessed among women who had T2DM (n = 97) and controls (n = 95) using Kaplan-Meier survival analysis and Cox proportional hazards modeling. The women with T2DM had higher baseline weight (body mass index, P < 0.01) and lower insulin sensitivity (homeostasis assessment model of insulin resistance, P < 0.01). The 8-year incidence rate among cases and controls was 13.4% and 5.8%, respectively (relative risk = 2.3). Obese cases had a fivefold risk of T2DM developing (P < 0.01) compared with age-adjusted obese controls, indicating significant interaction between PCOS and obesity to effect T2DM risk.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 1.Yen SS: Chronic anovulation caused by peripheral endocrine disorders. In Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management, edn 2. Edited by Yen S, Jaffe R. Philadelphia: W.B. Saunders Co.; 1986:576–630.Google Scholar
- 5.Kiddy DS, Hamilton-Fairley D, Bush A, et al.: Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol 1992, 36:105–111.Google Scholar
- 16.Talbott EO, Zborowski JV, Boudreaux MY: Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? A review of the evidence. Minerva Ginecol 2004, 56:27–39. This review of cardiovascular risk in women with PCOS significantly contributed to the literature through comprehensive review of clinical and subclinical factors through which PCOS may affect cardiovascular profiles of affected women. The longitudinal data used in compiling this review are unique in that there was longer duration of follow-up than normally available in other PCOS cohorts and in the older subset of women used in assessing risk.PubMedGoogle Scholar
- 18.Norman RJ, Masters L, Milner CR, et al.: Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Hum Reprod 2001, 16:1995–1998. Norman et al. did the only other pure incidence assessment of T2DM among women with PCOS. Their contribution showed the early impact of PCOS on development and T2DM through use of a relatively young population and their results highlighted how early differentiation between PCOS and non-PCOS affected groups can be seen.PubMedCrossRefGoogle Scholar
- 19.Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus [no authors listed]. Diabetes Care 1997, 20:1183–1197.Google Scholar
- 20.Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19–25.Google Scholar
- 26.Bonora E, Targher G, Alberiche M, et al.: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000, 23:57–63.PubMedCrossRefGoogle Scholar